scholarly journals Neuroendoscopic Transventricular Approach for Cystic Craniopharyngioma

Cureus ◽  
2021 ◽  
Author(s):  
Mohammad Hassan A Noureldine ◽  
Sajjad Khodmehr ◽  
Mohammadmahdi Sabahi ◽  
Puya Alikhani ◽  
George I Jallo ◽  
...  
2021 ◽  
Vol 25 ◽  
pp. 101120
Author(s):  
Mohd. Kaif ◽  
Kuldeep Yadav ◽  
Amit Kumar Upadhyay ◽  
Deepak Kumar Singh ◽  
Rakesh Kumar Singh ◽  
...  

2014 ◽  
Vol 38 (3) ◽  
pp. 149-152
Author(s):  
Amandeep Kumar ◽  
Ankit Bansal ◽  
Ajay Garg ◽  
Bhawani S. Sharma

2004 ◽  
Vol 44 (8) ◽  
pp. 408-415 ◽  
Author(s):  
Yukiko NAKAHARA ◽  
Hisao KOGA ◽  
Kenji MAEDA ◽  
Masashi TAKAGI ◽  
Kazuo TABUCHI

1984 ◽  
Vol 24 (12) ◽  
pp. 954-957 ◽  
Author(s):  
Kaichi TOKIWA ◽  
Kenji NAKAYAMA ◽  
Yoshio MIYASAKA ◽  
Kuniaki MATSUMORI ◽  
Toshio BEPPU ◽  
...  

2020 ◽  
Vol 15 (4) ◽  
pp. 846
Author(s):  
Somil Jaiswal ◽  
Manish Jaiswal ◽  
Pooja Jaiswal ◽  
Ankur Bajaj ◽  
Chhitij Srivastava ◽  
...  

2007 ◽  
Vol 107 (4) ◽  
pp. 318-323 ◽  
Author(s):  
Lucie Lafay-Cousin ◽  
Ute Bartels ◽  
Charles Raybaud ◽  
Abhaya V. Kulkarni ◽  
Sharon Guger ◽  
...  

Author(s):  
Dwight Parkinson ◽  
Michael West

SUMMARY:This is a report of a giant cystic craniopharyngioma which escaped diagnosis for nine years in spite of seemingly thorough neuroradiological investigation, prior to the advent of the CT scan.


2011 ◽  
Vol 69 (1) ◽  
pp. 50-55 ◽  
Author(s):  
Patrícia Alessandra Dastoli ◽  
Jardel Mendonça Nicácio ◽  
Nasjla Saba Silva ◽  
Andrea Maria Capellano ◽  
Silvia R.C. Toledo ◽  
...  

OBJECTIVE: To assess whether the cystic craniopharyngiomas can be controlled with the use of intratumoral applications of interferon alpha. METHOD: Nineteen patients with the diagnosis of cystic craniopharyngioma were treated with intratumoral chemotherapy with interferon alpha from January 2002 to April 2006. All patients underwent placement of an intracystic catheter connected to an Ommaya reservoir. Through this reservoir were made applications during chemotherapy cycles. Each cycle corresponded to application of 3,000,000 units of interferon alpha three times per week on alternate days totalizing 36,000,000 units. Response to treatment was evaluated by calculating the tumor volume on MRI control after one, three and six months after the end of each cycle. Patients who developed worsening of symptoms or who had insignificant reduction in tumor volume during follow-up underwent repeat cycle chemotherapy. RESULTS: Four patients received four cycles of chemotherapy, three patients received three cycles, six patients received two cycles and six patients received one. The lower percentage of reduction in tumor volume was 60% and the bigger reduction was 98.37%. Eleven patients had a reduction greater than 90%. Five patients had a tumor reduction between 75 and 90% and in three patients the tumors were reduced by less than 75%. No deaths occurred during treatment and side effects of interferon alpha were well tolerated. No treatment was discontinued. Follow-up after the last application ranged from one year and five months to three years and nine months. CONCLUSION: The intratumoral chemotherapy with interferon alpha decreases the volume of cystic craniopharyngiomas and so far can be considered a new therapeutic alternative.


Sign in / Sign up

Export Citation Format

Share Document